← Browse by Condition
Medical Condition

advanced colorectal cancer in the third line treatment and beyond

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06930118 Phase 2
Recruiting

The Aim of This Study is to Assess the Efficacy and Safety of Chidamide, Regorafenib in Combination With Iparomlimab and Tuvonralimab for the Treatment of Advanced Colorectal Cancer in Third-line Therapy and Subsequent Lines.

Enrollment
60 pts
Location
China
Sponsor
Shanghai Changzheng Hospital
View Trial →